BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24035822)

  • 21. Menopause and mental well-being: timing of symptoms and timing of hormone treatment.
    Pluchino N; Bucci F; Cela V; Cubeddu A; Genazzani AR
    Womens Health (Lond); 2011 Jan; 7(1):71-80. PubMed ID: 21175392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Menopausal hormone replacement therapy and quality of life].
    Salmi T
    Duodecim; 1996; 112(12):1035-6. PubMed ID: 10593002
    [No Abstract]   [Full Text] [Related]  

  • 23. Estrogen: a neuroprotective or proinflammatory hormone? Emerging evidence from reproductive aging models.
    Sohrabji F
    Ann N Y Acad Sci; 2005 Jun; 1052():75-90. PubMed ID: 16024752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hormonal factors and respiratory health in women--a review.
    Real FG; Svanes C; Macsali F; Omenaas ER
    Clin Respir J; 2008 Oct; 2 Suppl 1():111-9. PubMed ID: 20298359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
    Colditz GA; Hankinson SE; Hunter DJ; Willett WC; Manson JE; Stampfer MJ; Hennekens C; Rosner B; Speizer FE
    N Engl J Med; 1995 Jun; 332(24):1589-93. PubMed ID: 7753136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
    Brinton RD
    Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tamoxifen, hormone receptors and hormone replacement therapy in women previously treated for breast cancer: a cohort study.
    Dew JE; Wren BG; Eden JA
    Climacteric; 2002 Jun; 5(2):151-5. PubMed ID: 12051110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential effects of estrogen-androgen and estrogen-only therapy on vasomotor symptoms, gonadotropin secretion, and endogenous androgen bioavailability in postmenopausal women.
    Simon J; Klaiber E; Wiita B; Bowen A; Yang HM
    Menopause; 1999; 6(2):138-46. PubMed ID: 10374221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hormone replacement therapy and its role in the menopause.
    Holmes S
    Nurs Times; 1996 Jul 10-16; 92(28):34-9. PubMed ID: 8718078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Menopausal hormones and risk of ovarian cancer.
    Moorman PG; Schildkraut JM; Calingaert B; Halabi S; Berchuck A
    Am J Obstet Gynecol; 2005 Jul; 193(1):76-82. PubMed ID: 16021062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaginal estrogen in the treatment of genitourinary syndrome of menopause and risk of endometrial cancer: an assessment of recent studies provides reassurance.
    Pinkerton JV; Kaunitz AM; Manson JE
    Menopause; 2017 Dec; 24(12):1329-1332. PubMed ID: 29040220
    [No Abstract]   [Full Text] [Related]  

  • 34. Hormone therapy and the impact of estrogen intake on the risk of ovarian cancer.
    Glud E; Kjaer SK; Thomsen BL; Høgdall C; Christensen L; Høgdall E; Bock JE; Blaakaer J
    Arch Intern Med; 2004 Nov; 164(20):2253-9. PubMed ID: 15534163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Menopause: when hormone replacement therapy is not an option. Part I.
    Waldman TN
    J Womens Health; 1998 Jun; 7(5):559-65. PubMed ID: 9650156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The breast cancer "plunge" after initial publication of the WHI results: an alternative explanation.
    Simon JA; Nahum GG; Stanislaw H; Gaines T
    Maturitas; 2010 Jul; 66(3):277-84. PubMed ID: 20471761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postmenopausal hormone therapy and asthma-related hospital admission.
    Bønnelykke K; Raaschou-Nielsen O; Tjønneland A; Ulrik CS; Bisgaard H; Andersen ZJ
    J Allergy Clin Immunol; 2015 Mar; 135(3):813-6.e5. PubMed ID: 25579482
    [No Abstract]   [Full Text] [Related]  

  • 39. Physiologic aspects of natural and surgical menopause.
    Bachmann G
    J Reprod Med; 2001 Mar; 46(3 Suppl):307-15. PubMed ID: 11310451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogens and the skin.
    Brincat MP; Baron YM; Galea R
    Climacteric; 2005 Jun; 8(2):110-23. PubMed ID: 16096167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.